Home / Research library / BAM15 Capsules
BAM15 Capsules: molecular data, studies & sources
BAM15 Capsules is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
Molecular record not yet resolved
A sufficiently specific molecular record was not resolved for this name. Formula, molecular weight and structure are withheld until the exact sequence, salt or preparation can be verified.
MF: not assigned · MW: not assigned · Structure: not assigned
Registered clinical trials
Studies registered on ClinicalTrials.gov that list BAM15 as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received BAM15, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Preclinical / laboratory research
BAM15 treats mouse sepsis and kidney injury, linking mortality, mitochondrial DNA, tubule damage, and neutrophils.
Tsuji N, Tsuji T, Yamashita T et al. · The Journal of clinical investigation · 2023
PMID 36757801 · DOI: 10.1172/JCI152401
- Preclinical / laboratory research
Beneficial effects of MGL-3196 and BAM15 combination in a mouse model of fatty liver disease.
Zhou M, Li C, Byrne FL et al. · Acta physiologica (Oxford, England) · 2024
PMID 39152636 · DOI: 10.1111/apha.14217
- Review · secondary evidence
BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases.
Xiong G, Zhang K, Ma Y et al. · Frontiers in endocrinology · 2023
PMID 37900126 · DOI: 10.3389/fendo.2023.1252141
- Research publication · design requires review
BAM15 inhibits endothelial pyroptosis via the NLRP3/ASC/caspase-1 pathway to alleviate atherosclerosis.
Zhong S, Shen H, Dai X et al. · Atherosclerosis · 2025
PMID 40393254 · DOI: 10.1016/j.atherosclerosis.2025.119226
- Preclinical / laboratory research
BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control.
Axelrod CL, King WT, Davuluri G et al. · EMBO molecular medicine · 2020
PMID 32519812 · DOI: 10.15252/emmm.202012088
- Research publication · design requires review
BAM15 Relieves Neurodegeneration in Agedand Extends Lifespan.
Cho I, Song HO, Ji HE et al. · Metabolites · 2022
PMID 36422268 · DOI: 10.3390/metabo12111129
- Preclinical / laboratory research
The new mitochondrial uncoupler BAM15 induces ROS production for treatment of acute myeloid leukemia.
Gao ZX, Cui ZL, Zhou MR et al. · Biochemical pharmacology · 2022
PMID 35192847 · DOI: 10.1016/j.bcp.2022.114948
- Research publication · design requires review
Mitochondrial uncoupler BAM15 ameliorates liver lipid metabolism disorders by activating the AMPK pathway.
Liu Z, Wang W, Wang S et al. · The FEBS journal · 2026
PMID 41527408 · DOI: 10.1111/febs.70400
BAM15 Capsules supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
No priced supplier offers are currently available in this catalog view. The research record remains available independently of stock.
Reference sources & further reading
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
ACE-031
Molecular identity needs further verification
3 selected publications · 2 human intervention studies · 4 registered trials
Adipotide
C111H206N36O28S2
2557.2 g/mol · PubChem CID 163360068
1 selected publication · 0 human intervention studies
AICAR
C9H14N4O5
258.23 g/mol · PubChem CID 17513
4 selected publications · 3 human intervention studies · 4 registered trials
Small molecule · highest stage: Phase 3
B7-33
Molecular identity needs further verification
4 selected publications · 0 human intervention studies
Dermorphin
C40H50N8O10
802.9 g/mol · PubChem CID 5485199
1 selected publication · 1 human intervention study
Enclomiphene
C26H28ClNO
406.0 g/mol · PubChem CID 1548953
5 selected publications · 3 human intervention studies · 22 registered trials
Small molecule · highest stage: Phase 3